Needham & Company LLC restated their buy rating on shares of Geron (NASDAQ:GERN – Free Report) in a report published on Friday morning, Benzinga reports. Needham & Company LLC currently has a $4.00 price objective on the biopharmaceutical company’s stock. Geron Stock Performance Geron stock remained flat at $2.92 during mid-day trading on Friday. The […]
Geron Co (NASDAQ:GERN) Receives $5 00 Average Target Price from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Geron Co. (NASDAQ:GERN – Free Report)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.79 and traded as high as $3.26. Geron shares last traded at $3.18, with a volume of 1,944,400 shares trading hands. Analysts Set New Price Targets A number […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) saw some unusual options trading activity on Friday. Stock traders purchased 2,809 put options on the company. This represents an increase of 85% compared to the typical daily volume of 1,517 put options. BioMarin Pharmaceutical Stock Performance BioMarin Pharmaceutical stock traded down $0.61 during mid-day trading on Friday, […]
Gulf International Bank UK Ltd decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 20.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,359 shares of the biotechnology company’s stock after selling 6,529 shares during the period. Gulf […]